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Abstract
Background:  Despite the characteristic extensive tubulointerstitial fibrosis, Balkan Endemic
Nephropathy (BEN) is usually considered a non-inflammatory disease.
Methods: We examined a marker of inflammation, C-reactive protein (CRP), in the offspring of
patients with BEN, a population at risk for BEN, prior to development of established disease to
determine if an inflammatory process could be identified in the early stages of the disease. In 2003/
04, 102 adult offspring whose parents had BEN and a control group of 99 adult offspring of non-
BEN patients were enrolled in this prospective study. This cohort was re-examined yearly for four
consecutive years. Levels of serum CRP were measured in years 3 and 4 and compared between
groups. The data were analyzed with mixed models.
Results: Compared to controls, offspring of BEN parents had statistically higher CRP levels in two
consecutive years, suggestive of early inflammatory reactivity. Whenever the mother was affected
by BEN (both parents, or mother only), serum CRP was significantly increased, but not if only the
father had BEN. CRP was inversely related to kidney cortex width but not to markers or renal
function.
Conclusion: Early stages of BEN may involve inflammatory processes. The observation of a
maternal involvement supports the concept of fetal programming, which has been implicated in the
pathogenesis of other chronic kidney diseases.
Background
Balkan Endemic Nephropathy (BEN) is a tubulointersti-
tial kidney disease which final stage is characterized by
renal failure and shrinkage of both kidneys [1]. Cases of
BEN were first described in Bulgaria in 1956 [2], then in
Yugoslavia in 1957 [3], and in Romania in 1961 [4]. In
1964, this disease was recognized as a new nosological
entity, although its causes are still unknown. The number
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of people diagnosed with BEN is at least 25,000, while
approximately 100,000 persons are at risk [5]. Although
this disease is endemic in rural areas of the Balkan,
endemic nephropathies are reported to occur in other
regions too. For instance, chronic kidney diseases of
uncertain etiology, which resemble BEN, have been
reported in Sri Lanka (personal communication, Dr.
Alturaliya, Sri Lanka) [6]. In the past 50 years, etiologic
explanations have emerged emphasizing for instance lig-
nites or organic substances from coal [5,7], aristolochic
acid [8], ochratoxin A [9], metals, and metalloids [10-13].
However, these claims are often not substantiated by suf-
ficient evidence or scientific studies. For instance, we
recently reported negative findings for metals and metal-
loids [14]. Or regarding aristolochic acid, there are no
published scientific studies that provide biological evi-
dence of association between aristolochic acid exposure
and incidence or prevalence of BEN in humans [15,16].
To our understanding, there is no sound explanation of
risk factors for BEN, only lack of knowledge.
Regarding the clinical features of the disease, a number of
descriptions that emerged in the 1950s and 1960s also did
not result from thorough scientific inquiries. Hence, we
need scientifically sound investigations of basic assump-
tions. One is, that BEN develops without inflammation
and that it progresses slowly over many years [17,18].
Because BEN is usually diagnosed in its late stage, there
are few studies describing earlier stages of its develop-
ment. However, this restriction limits evaluation on
whether inflammatory mechanisms were involved in the
beginning. Established BEN is characterized by marked
tubulointerstitial fibrosis and tubule atrophy without evi-
dence of significant inflammatory cell infiltration. This
has been taken as evidence that BEN is not an inflamma-
tory disease. However, it is hard to imagine how such
marked tubulointerstitial destruction can occur without
inflammation. We therefore decided to investigate CRP as
a marker of inflammation in subjects at risk for BEN but
without established disease, to determine if evidence for
inflammation could be detected early during the course of
BEN. CRP is an acute phase protein whose synthesis in the
liver is regulated by different cytokines. Plasma levels of
CRP in the absence of active disease are low, but can rise
up to a thousand-fold in patients with an inflammatory
reaction [19].
This became our motivation for a follow-up study investi-
gating clinical markers of Balkan Endemic Nephropathy
in a cohort at risk of the disease at an early stage. We
recruited adult offspring of BEN patients and compared
these with non-BEN offspring. Earlier, we demonstrated
that kidney length and minimal cortex width in BEN off-
spring were significantly decreased if the mother had BEN
[20]. Additionally, blood pressure, as well as urine con-
centrations of total protein, albumin and β2-microglobu-
lin, were higher in the maternal BEN offspring [20,21].
However, using laboratory and clinical criteria, in 2006/
07 none of the offspring had yet been diagnosed of having
BEN. For this analysis, we hypothesized that adult off-
spring of BEN patients have increased levels of CRP, in
particular if their mother had BEN. Because we detected
significantly increased CRP levels in the 2005/06 investi-
gations, we repeated the CRP analysis in 2006/07 to test
whether we could substantiate our initial findings and
whether this is an ongoing inflammatory state.
Methods
Population
From October 2003 to April 2004, we recruited 102 adult
offspring whose father and/or mother were included in
the Vratza Hospital registry of BEN patients in Bulgaria in
2001 and who resided in one of three communities
(Vratza, Bistretz, and Beli Izvor in Bulgaria). The diagnosis
of BEN in the parent generation was based on published
criteria [22]. A control group of nearly equal size, 99 adult
offspring of non-BEN hospitalized patients, was enrolled
in the study during the same time period. Diagnoses in
controls' parents included diabetes mellitus, and cardio-
vascular and liver disorders. Only three of the 99 controls
had parents with kidney disorders (one paternal kidney
cancer not related to BEN, and two maternal pyelonephri-
tis cases). Subjects of both groups were frequency-
matched according to gender and ten-year age groupings.
In the third examination (2005/06), a parent of one con-
trol participant had developed BEN [20,21]. Thus, this
participant was moved into the BEN offspring group for
analyses of this and subsequent years.
All participants provided written consent through a proce-
dure approved by the Institutional Review Board
(Human-Subject Research Committee) of the National
Center of Public Health Protection, Sofia, Bulgaria. This
population was re-examined in 2004/05, 2005/06, and
2006/07.
Interviews
We conducted face-to-face interviews with all participants
either in the hospital, or by visiting them in their home
village. The standardized questionnaire included their
family history of BEN and of other kidney diseases.
Physical examination and CRP measurement
Physical examinations were performed by an experienced
physician with board certifications in internal diseases
and nephrology. No patient showed clinical signs of
inflammation or infection during the study period. Blood
pressure was measured according to protocols established
by the World Health Organization [23]. Venous blood for
the determination of CRP was drawn in K2EDTA Vacutain-BMC Nephrology 2009, 10:10 http://www.biomedcentral.com/1471-2369/10/10
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ers® in the third and fourth investigation in 2005/06 and
2006/07. Blood samples were centrifuged and serum CRP
was measured with IMMULITE® chemiluminescent immu-
nometric assay. The expected value for healthy volunteers
is 0.14 mg/dL and the upper 97.5 percentile is 1.1 mg/dL.
To determine whether CRP levels are related to having a
parent with BEN, we compared CRP levels in the offspring
of these two groups. Second, to determine whether mater-
nal or paternal history of BEN was involved, we grouped
parental disease status into four categories: mother, father,
both parents, and none affected. The comparison off-
spring included only parents not affected by BEN (refer-
ence group). As CRP was not normally distributed, we
applied non-parametric tests (Kruskal-Wallis) for descrip-
tive purposes.
Statistical Analyses
The repeated measurements in 2005/06 and 2006/07
were not independent, hence, we used mixed models
(PROC MIXED) adjusting for within-participant effects
[24]. We used the regular maximum likelihood method of
estimation. Linear mixed models require that the random
effects and the error vector were normally distributed. To
achieve this, we log-transformed the CRP values, thereby
providing geometric means for the various risk factors in
the CRP explanatory model. For the within-subject associ-
ation, we used an unstructured covariance model, which
requires the least amount of constraints. For the repeated
covariance structure, the variance component provided
the best fit (Akaike Information Criterion). We performed
data analyses using SAS version 9.1 (SAS Institute Inc.,
Cary, NC, USA).
The two risk factors of interest were parental history of
BEN (yes vs. no) and a four-level categorization of this
variable: mother, father, both parents, and none affected.
Statistically, we controlled for gender, age, smoking in the
last 12 months, ex-smoking, body-mass index (BMI: kg/
m2), history of diseases of the urogenital system, diabetes
mellitus, and medication. For each year, based on their
history, participants were categorized into active smokers
and ex-smokers. Statistically we controlled for the follow-
ing urogenital diseases in the offspring: cystitis, pyelone-
phritis, kidney stones, and other kidney diseases (e.g.,
cancer: n = 2, and hydronephrosis n = 1). In addition, we
treated diabetes in the participant as a potential con-
founder, since it can affect both the kidneys and inflam-
matory markers. To classify diabetes, we used information
provided by the participant in addition to serum glucose
measurements. Once participants stated that they had dia-
betes in one of the four years, they were classified as dia-
betic for that and the subsequent year(s). If serum glucose
was higher than 6.2 mmol/L in at least two years, we also
classified the participant as diabetic. Regarding medica-
tion, we adjusted for anti-diabetes drugs (thiazolidinedi-
ones and others), beta-blockers, and steroid hormones.
Results
C-reactive protein was determined in the third and fourth-
year follow-up: 2005/06 and 2006/07. Of the initial 201
participants (2003/04), 182 participated in the third
investigation (90%) in 2005/06. In addition, 18 new off-
spring of BEN parents were recruited in 2005/06 (total of
200 participants, table 1). In year 3, the father of one con-
trol participant developed BEN. Thus, this participant was
re-allocated. In year 4, 193 participants were included.
There were no significant differences in the distributions
of gender, age, smoking, and body mass index in the off-
spring of BEN and the control group. Pyelonephritis, kid-
ney stone, and use of beta-blockers were reported more
frequently in the offspring of BEN patients.
Due to a communication error with the laboratory, CRP
was only determined in 141 of the enrolled participants;
in 77% of those with parental BEN, and in 78% of adults
without parental history of BEN. In the fourth year, we
had 190 CRP measurements from 200 participants (table
2). Unadjusted median levels of CRP in the offspring of
BEN parents were 0.56 mg/dL (5–95% values: 0.07–2.92
mg/dL) and 0.29 mg/dL in controls (5–95% values: 0.06–
2.04 mg/dL, p < 0.001). In both measurement periods,
whenever the mother was affected by BEN (either both
parents or maternal history) serum CRP was significantly
higher (table 2). This was not seen if only the father had a
history of BEN. CRP levels in the two consecutive years
showed a moderate and statistically significant rank corre-
lation (rSpearman = 0.586, n = 151, p < 0.0001).
In repeated measurement models, being a BEN offspring
was significantly associated with higher CRP levels (table
3). In addition, a maternal history of BEN (mother and/or
both parents) was related to a higher CRP. Other impor-
tant risk factors for higher CRP levels were age, increased
body mass index, and smoking. Table 4 shows the esti-
mated geometric means for CRP. When the mother had
BEN, CRP is 0.58 mg/dL, and with both parents CRP is
0.64 mg/dL. There is no difference between control and
paternal BEN (0.42 and 0.43 mg/dL). The descriptive
(table 2) and the repeated measurement analyses (table 4)
thus show comparable findings.
During the course of examinations over three years (2003/
04, 2004/05, 2005/06) CRP was not systematically corre-
lated with excretion of total protein, albumin, beta2-
microglobulin, creatinine clearance (Cockcroft and
Gault), nor with kidney length (data not shown, for meth-
ods see [20]). However, we found that CRP was inversely
related to kidney cortex width, determined by ultrasound
measurements (table 5). The negative correlationBMC Nephrology 2009, 10:10 http://www.biomedcentral.com/1471-2369/10/10
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Table 1: Population characteristics of the follow-up study on Balkan Endemic Nephropathy
Investigation in 2005–2006 Investigation in 2006–2007
Offspring of BEN cases Offspring of control 
patients
Offspring of BEN cases Offspring of control 
patients
n = 106
%
n = 94
%
n = 101
%
n = 92
%
Parental history of BEN Both 30.2 0 30.7 0
Mother only 32.1 0 32.7 0
Father only 37.4 0 36.6 0
n o n e 01 0 001 0 0
Gender male 47.2 46.8 47.5 46.7
Age (years) ≤ 40 11.3 21.3 8.9 19.6
40–50 35.9 34.0 35.6 34.8
> 50–60 34.0 29.8 34.7 30.4
60 & older 18.9 14.9 20.8 15.2
Smoking in the last 12 
mths
37.5 38.3 35.6 35.9
Ex-smoking 21.6 10.4 16.8 13.4
History of: pyelonephritis 8.5 2.1 8.9 2.2
kidney stones 9.4 6.4 11.9 5.4
cystitis 5.7 6.4 5.9 6.5
other kidney diseases 3.8 2.1 5.9 2.2
Diabetes mellitus 2.8 7.5 5.9 8.7
Report of application of
the following medications:
Anti-diabetics
0 . 92 . 12 . 02 . 2
Beta-blockers 8.5 1.1 7.0 2.2
Steroid hormones 6.0 0 0 2.2
Median (5 – 98% value)
Age (years) 51 (38–65) 48 (34–65) 52 (39–65) 49 (34–66)
Body-mass index (kg/m2) 28.0 (19.5–35.7) 26.3 (21.4–33) 28.5 (19.8–35.0) 27.2 (21.5–34.3)
Table 2: Concentration of C-reactive protein and in adult offspring and parental history of BEN#
Variable Parents had BEN No parent affected
n Median 5–95% value n Median 5–95% value
C-reactive protein (mg/
dL) 2005/06
85 0.56 0.07–2.92 74 0.29 0.06–2.04
p-value 0.0028 reference
C-reactive protein (mg/
dL) 2006/07
99 0.36 0.07–3.41 91 0.22 0.05–1.66
p-value 0.004
Both parents had BEN Mother had BEN Father had BEN No parent affected
n Median 5–95% value n Median 5–95% value n Median 5–95% value n Median 5–95% value
C-reactive protein (mg/
dL) 2005/06
23 0.88 0.07–4.53 31 0.68 0.15–2.92 31 0.33 0.05–1.36 74 0.29 0.06–2.04
p-value 0.001 0.003 0.65 reference
C-reactive protein (mg/
dL) 2006/07
31 0.47 0.09–4.03 36 0.41 0.06–3.41 32 0.30 0.06-.171 91 0.22 0.05–1.66
p-value 0.007 0.015 0.61 reference
# p-values based on Kruskal-Wallis test.BMC Nephrology 2009, 10:10 http://www.biomedcentral.com/1471-2369/10/10
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increased over the course of the investigations. No ultra-
sound measurements were conducted in 2007/08, the lat-
est year of CRP measurements.
Discussion
Our results show that being an offspring of BEN parents is
associated with increased CRP background levels in two
consecutive years, indicative of an inflammatory state in
the adult offspring. Interestingly, a maternal history of
BEN is a significant risk factor for higher background CRP
levels in offspring, but paternal BEN is not.
Our findings are unlikely to have resulted from selection
bias, since the retention of this cohort is high. It is also
unlikely that the results are chance findings, since we
found the same results for CRP in two consecutive years.
CRP serum concentrations in our sample of healthy adults
were within the range reported by other investigations
[25,26]. We did find the classical risk factors (age, body
mass index, and smoking) related to CRP [27,28]. There
are numerical differences between the 2005/06 and 2006/
07 measurements; the values in 2005/06 were higher. The
variations may be due to different individual situations,
season, infections, or measurement errors. However,
despite these variations, the described effects in the four
groups remained stable in two consecutive years. In addi-
tion, we also investigated whether the prior or current
occupational status affected CRP levels or the association
between parental history of BEN and CRP. We found that
employees in the agricultural or transport sector had
higher CRP levels (data not shown). Since these occupa-
tions were not differentially distributed among BEN and
control offspring, the occupational status did not con-
found the association between paternal history and CRP.
Based on the paucity of inflammatory cell infiltration in
kidney biopsy specimens, it has generally been thought
that the extensive fibrosis and tubular atrophy seen in
BEN is not an inflammatory process. Tatu et al., reported
that levels of inflammatory cytokines and CRP were nor-
Table 3: Effect of being an offspring of a BEN patient on the level of C-reactive protein#
Repeated measurement-analysis:
200 participants, 349 observations
Model comparing offspring BEN status Model comparing parental history of BEN
Parameter
Estimate¥
p-value (t-test) Parameter
Estimate†
p-value (t-test)
Offspring of BEN patient vs offspring of control patient 0.102 0.043 -
Parental history of BEN:
both - 0.189 0.01
mother - 0.146 0.03
father - 0.013 0.85
none - Reference
Age (years) 0.012 < 0.0001 0.01 0.0005
Gender (female) 0.073 0.178 0.06 0.26
Body-mass index 0.038 < 0.0001 0.038 < 0.0001
Smoking in the last 12 months 0.157 0.007 0.153 0.009
# CRP (mg/dL) is log 10 transformed
¥ Statistically controlled for ex-smoking, history of pyelonephritis, cystitis, other kidney diseases
† Statistically controlled for ex-smoking, history of cystitis, administration of steroid hormones
Table 4: Adjusted geometric means for C-reactive protein comparing offspring status and parental history of BEN†
C-reactive protein (mg/dL)
Repeated measurement analysis
(200 participants, 349 observations)
Adjusted geometric mean 5–95% confidence limit p-value
(F-test)
Offspring of BEN patient 0.62 0.41 0.94 0.04
Offspring of control patient 0.49 0.31 0.77
Parental history of BEN:
both 0.64 0.41 1.0 0.026
mother 0.58 0.37 0.91
father 0.43 0.27 0.68
none 0.42 0.28 0.63
† Statistically controlled for ex-smoking, history of cystitis, administration of steroid hormonesBMC Nephrology 2009, 10:10 http://www.biomedcentral.com/1471-2369/10/10
Page 6 of 7
(page number not for citation purposes)
mal in most BEN cases [7], which would support the posi-
tion that BEN is not an inflammatory disease, but their
results remain unpublished. In contrast, in earlier presen-
tation including 11 BEN patients, Dimitrov et al. reported
increased erythrocyte sedimentation rate, a non-specific
measure of inflammation[29] Also Toncheva et al. sug-
gested that immune-mediated inflammatory processes
may be involved in some patients [30]. Interestingly, CRP
levels were inversely correlated with the kidney cortex
width measured by ultrasound (table 5), but not with kid-
ney length or other measured renal functions. It is possi-
ble, that CRP as an inflammatory marker is related to a
reduction in the cortex width due to atrophy and intersti-
tial scarring.
We found that a maternal history of BEN was a risk factor
for increased CRP in the offspring. Earlier, we docu-
mented that the offspring of BEN parents had higher
systolic and pulse pressure [21]. In addition, in this anal-
ysis we found that CRP levels are significantly correlated
with systolic blood pressure (Spearman correlation coeffi-
cient: 0.33, p < 0.001 in 2005/06). This result is in agree-
ment with prior reports that CRP is a risk factor for
hypertension [20,25]. We believe that our findings
emphasize the need for rigorous clinical-epidemiologic
research to determine features and identify the inflamma-
tory mechanisms of the disease that are comparable to
other groups of renal pathologies.
Why could a maternal history of BEN be associated with a
higher risk of BEN? We speculate that maternal condi-
tions, for instance antibodies against kidney tissue, during
pregnancy, at an age before the mother is diagnosed with
BEN, may alter the development and the susceptibility of
the offspring kidneys. The concept of prenatal program-
ming may provide a new explanation for the observed
family disposition of BEN.
This suspicion is further supported by prior findings
showing that kidney size and function and blood pressure
were also more strongly associated with a maternal his-
tory of BEN[20,21] However, this does not exclude the
fact that environmental factors may have initiated and
also sustained the maternal-offspring interaction. The
idea that fetal programming is involved in BEN, [31] is
further corroborated by research showing that fetal pro-
gramming may also be involved in the pathogenesis of
other chronic kidney diseases [32-34] Since cases of Bal-
kan Endemic Nephropathy are registered and easily acces-
sible in various Balkan countries, BEN may serve as a
future model for determining the role of fetal program-
ming in renal health.
Conclusion
We found that offspring of patients with Balkan Endemic
Nephropathy have higher CRP serum levels than offspring
of parents without the disease. This finding suggests that
inflammatory processes are involved in the pathogenesis
of BEN. The maternal contribution to the susceptibility to
BEN lends support to the evidence that prenatal program-
ming may instigate a higher risk for developing BEN.
Since two-generation studies can easily be established for
Balkan Endemic Nephropathy, investigations into BEN
provide an opportunity to characterize prenatal program-
ming of kidney diseases in general.
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